You are here: Industry Insights > antibody

News List

AbbVie and partners to develop monoclonal antibody against Covid-19 pharmaceutical-technology
June 09, 2020
AbbVie has partnered with Harbour BioMed (HBM), Utrecht University (UU) and Erasmus Medical Center (EMC) to develop a monoclonal antibody therapeutic for the prevention and treatment of Covid-19.
Shanghai Junshi Biosciences starts human tests for coronavirus antibody drug expresspharma
June 08, 2020
The experimental drug, JS016, is also expected to begin human study in the US in the second quarter of this year, through collaboration with Eli Lilly and Co.
Lilly launches Phase I trial of investigational COVID-19 antibody treatment europeanpharmaceuticalreview
June 05, 2020
The enterprise announced the initiation of the LY-CoV555 COVID-19 antibody treatment trial at medical centres across the US.
Memo Therapeutics discovers neutralising antibodies against Covid-19 pharmaceutical-technology
June 05, 2020
Switzerland-based Memo Therapeutics has discovered multiple SARS-CoV-2 neutralising antibodies with the potential for development as immunotherapy against Covid-19.
Lilly, AbCellera Dose First Patients with COVID-19 Antibody contractpharma
June 02, 2020
Phase 1 study of LY-CoV555 is the world's first study of a potential antibody treatment designed to fight COVID-19.
AbCellera raises $105m for antibody drug discovery platform pharmaceutical-technology
May 28, 2020
Canadian biotech firm AbCellera Biologics has raised $105m in a Series B funding round to advance its artificial intelligence (AI)-powered antibody drug discovery platform.
Potential Anti-SARS-CoV-2 Antibody Able to Inhibit In Vitro Virus Infection in Preclinical Studies americanpharmaceuticalreview
May 19, 2020
Sorrento Therapeutics announced anti-SARS-CoV-2 antibody, STI-1499, demonstrated 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection experiment at a very low antibody concentration.
Sorrento’s antibody completely blocks Covid-19 in-vitro pharmaceutical-technology
May 19, 2020
Sorrento Therapeutics has reported that its Covid-19 therapeutic antibody candidate, STI-1499, can completely block the viral infection in-vitro during preclinical studies.
Vyriad to Develop Antibody Test to Determine COVID-19 Protective Immunity americanpharmaceuticalreview
May 18, 2020
Vyriad has completed the development of a serology test to measure protective immunity against SARS-CoV-2, the novel coronavirus that causes COVID-19.
FairJourney Biologics Joins Forces with Iontas contractpharma
May 14, 2020
FairJourney Biologics and Iontas, two Clinical Research Organizations (CROs) in antibody discovery services, have combined their operations to create an international platform and provide their industry leading services to global biopharma.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page